Dopamine D3 receptor alterations in cocaine-dependent humans imaged with [11C](+)PHNO

Drug and Alcohol Dependence

Volumn 139, Issue , 2014, Pages 100-105

  Matuskey, David ^a,b   Gallezot, Jean Dominique ^b   Pittman, Brian ^a   Williams, Wendol ^a,b   Wanyiri, Jane ^a   Gaiser, Edward ^a   Lee, Dianne E ^b   Hannestad, Jonas ^a   Lim, Keunpoong ^b   Zheng, Minq Qiang ^b   Lin, Shu fei ^b   Labaree, David ^b   Potenza, Marc N ^a   Carson, Richard E ^b   Malison, Robert T ^a   Ding, Yu Shin ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Dopamine; Human; PET

Indexed keywords

DOPAMINE 3 RECEPTOR; NAXAGOLIDE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; NAXAGOLIDE; OXAZINE DERIVATIVE;

ADULT; AGE DISTRIBUTION; AMYGDALOID NUCLEUS; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATIONAL STUDY; DOPAMINERGIC TRANSMISSION; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG TARGETING; DRUG UPTAKE; DRUG WITHDRAWAL; FEMALE; GLOBUS PALLIDUS; HELP SEEKING BEHAVIOR; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; ISOTOPE LABELING; MALE; PARAMETRIC TEST; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PUTAMEN; RECEPTOR BINDING; SINGLE DRUG DOSE; SUBSTANCE ABUSE; SUBSTANTIA NIGRA; THALAMUS; BRAIN; CASE CONTROL STUDY; DIAGNOSTIC USE; DRUG EFFECTS; METABOLISM; NEUROIMAGING; PATHOLOGY; PROCEDURES; SCINTISCANNING;

ANIMALIA;

ADULT; BRAIN; CASE-CONTROL STUDIES; COCAINE-RELATED DISORDERS; FEMALE; GLOBUS PALLIDUS; HUMANS; MALE; NEUROIMAGING; OXAZINES; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, DOPAMINE D3; SUBSTANTIA NIGRA;

EID: 84899919234     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.03.013     Document Type: Article

References (52)

1. Blaylock B.L., Nader M.A. Dopamine D3 receptor function and cocaine exposure. Neuropsychopharmacology 2012, 37:297-298.
2. 11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain 2009, 132:1366-1375.
3. 11C]raclopride. Addiction 2013, 108:953-963.
4. 11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J. Neurosci. 2012, 32:1353-1359.
5. Bordet R., Ridray S., Carboni S., Diaz J., Sokoloff P., Schwartz J.C. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:3363-3367.
6. Caine S.B., Koob G.F. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 1993, 260:1814-1816.
7. Caine S.B., Thomsen M., Barrett A.C., Collins G.T., Grundt P., Newman A.H., Butler P., Xu M. Cocaine self-administration in dopamine D3 receptor knockout mice. Exp. Clin. Psychopharmacol. 2012, 20:352-363.
8. Carson R.E., Barker W.C., Liow J.-S., Johnson C.A. Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction of the HRRT. Conference Record, IEEE Nuclear Science Symposium and Medical Imaging Conference 2003, 3281-3285.
9. Di Ciano P. Drug seeking under a second-order schedule of reinforcement depends on dopamine D3 receptors in the basolateral amygdala. Behav. Neurosci. 2008, 122:129-139.
10. Diaz M.R., Chappell A.M., Christian D.T., Anderson N.J., McCool B.A. Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral/basolateral amygdala. Neuropsychopharmacology 2011, 36:1090-1103.
11. Ersche K.D., Turton A.J., Chamberlain S.R., Muller U., Bullmore E.T., Robbins T.W. Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am. J. Psychiatry 2012, 169:926-936.
12. Gallezot J.D., Beaver J.D., Gunn R.N., Nabulsi N., Weinzimmer D., Singhal T., Slifstein M., Fowles K., Ding Y.S., Huang Y., Laruelle M., Carson R.E., Rabiner E.A. Affinity and selectivity of [(1)(1)C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo. Synapse 2012, 66:489-500.
13. 11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography. J. Neurochem. 2006, 97:1089-1103.
14. 11C]-(+)-PHNO binding in the human brain. J. Cereb. Blood Flow Metab. 2007, 27:857-871.
15. 11C]-(+)-PHNO PET study. Neuropsychopharmacology 2009, 34:1078-1086.
16. 11C]raclopride in healthy humans. Hum. Brain Mapp. 2008, 29:400-410.
17. Gu H., Salmeron B.J., Ross T.J., Geng X., Zhan W., Stein E.A., Yang Y. Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage 2010, 53:593-601.
18. Heidbreder C.A., Gardner E.L., Xi Z.X., Thanos P.K., Mugnaini M., Hagan J.J., Ashby C.R. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res. Brain Res. Rev. 2005, 49:77-105.
19. Heidbreder C.A., Newman A.H. Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders. Ann. N. Y. Acad. Sci. 2010, 1187:4-34.
20. Koob G.F. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur. Neuropsychopharmacol. 2003, 13:442-452.
21. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
22. Le Foll B., Goldberg S.R., Sokoloff P. The dopamine D3 receptor and drug dependence: effects on reward or beyond?. Neuropharmacology 2005, 49:525-541.
23. Lee D.E., Wilson B., Li C.S.R., Carson R.E. Evaluation of linear and nonlinear spatial transformation models for high resolution PET studies of small brain structures. J. Cereb. Blood Flow Metab. 2012, 32:S128-S191.
24. Makris N., Gasic G.P., Seidman L.J., Goldstein J.M., Gastfriend D.R., Elman I., Albaugh M.D., Hodge S.M., Ziegler D.A., Sheahan F.S., Caviness V.S., Tsuang M.T., Kennedy D.N., Hyman S.E., Rosen B.R., Breiter H.C. Decreased absolute amygdala volume in cocaine addicts. Neuron 2004, 44:729-740.
25. Martinez D., Broft A., Foltin R.W., Slifstein M., Hwang D.R., Huang Y., Perez A., Frankle W.G., Cooper T., Kleber H.D., Fischman M.W., Laruelle M. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 2004, 29:1190-1202.
26. Martinez D., Carpenter K.M., Liu F., Slifstein M., Broft A., Friedman A.C., Kumar D., Van Heertum R., Kleber H.D., Nunes E. Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. Am. J. Psychiatry 2011, 168:634-641.
27. Mawlawi O., Martinez D., Slifstein M., Broft A., Chatterjee R., Hwang D.R., Huang Y., Simpson N., Ngo K., Van Heertum R., Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J. Cereb. Blood Flow Metab. 2001, 21:1034-1057.
28. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 1998, 78:189-225.
29. 11C]-(+)-PHNO. Schizophr. Res. 2011, 131:63-68.
30. Mugnaini M., Iavarone L., Cavallini P., Griffante C., Oliosi B., Savoia C., Beaver J., Rabiner E.A., Micheli F., Heidbreder C., Andorn A., Merlo Pich E., Bani M. Occupancy of brain dopamine D(3) receptors and drug craving: a translational approach. Neuropsychopharmacology 2012, 38:302-312.
31. Neisewander J.L., Fuchs R.A., Tran-Nguyen L.T., Weber S.M., Coffey G.P., Joyce J.N. Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neuropsychopharmacology 2004, 29:1479-1487.
32. Newman A.H., Blaylock B.L., Nader M.A., Bergman J., Sibley D.R., Skolnick P. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem. Pharmacol. 2012, 84:882-890.
33. Payer D.E., Behzadi A., Kish S.J., Houle S., Wilson A.A., Rusjan P.M., Tong J., Selby P., George T.P., McCluskey T., Boileau I. Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [(11)C]-(+)-PHNO. Neuropsychopharmacology 2014, 39:321-328.
34. Schotte A., Janssen P.F., Bonaventure P., Leysen J.E. Endogenous dopamine limits the binding of antipsychotic drugs to D3 receptors in the rat brain: a quantitative autoradiographic study. Histochem. J. 1996, 28:791-799.
35. 11C]PHNO, and a selective D3 receptor antagonist. Biol. Psychiatry 2010, 68:392-399.
36. Seeman P. Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans. Synapse 2012, 66:88-93.
37. Shotbolt P., Tziortzi A.C., Searle G.E., Colasanti A., van der Aart J., Abanades S., Plisson C., Miller S.R., Huiban M., Beaver J.D., Gunn R.N., Laruelle M., Rabiner E.A. Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans. J. Cereb. Blood Flow Metab. 2012, 32:127-136.
38. Skinbjerg M., Sibley D.R., Javitch J.A., Abi-Dargham A. Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?. Biochem. Pharmacol. 2012, 83:193-198.
39. Smith R.J., Aston-Jones G. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct. Funct. 2008, 213:43-61.
40. Sokoloff P., Giros B., Martres M.P., Andrieux M., Besancon R., Pilon C., Bouthenet M.L., Souil E., Schwartz J.C. Localization and function of the D3 dopamine receptor. Arzneimittelforschung 1992, 42:224-230.
41. Staley J.K., Mash D.C. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J. Neurosci. 1996, 16:6100-6106.
42. Stalnaker T.A., Roesch M.R., Calu D.J., Burke K.A., Singh T., Schoenbaum G. Neural correlates of inflexible behavior in the orbitofrontal-amygdalar circuit after cocaine exposure. Ann. N. Y. Acad. Sci. 2007, 1121:598-609.
43. Stanwood G.D., Lucki I., McGonigle P. Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments. J. Pharmacol. Exp. Ther. 2000, 295:1232-1240.
44. 11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage 2011, 54:264-277.
45. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
46. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997, 386:830-833.
47. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Logan J., Childress A.R., Jayne M., Ma Y., Wong C. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci. 2006, 26:6583-6588.
48. Wells A.M., Arguello A.A., Xie X., Blanton M.A., Lasseter H.C., Reittinger A.M., Fuchs R.A. Extracellular signal-regulated kinase in the basolateral amygdala, but not the nucleus accumbens core, is critical for context-response-cocaine memory reconsolidation in rats. Neuropsychopharmacology 2012, 38:753-762.
49. Wong D.F., Kuwabara H., Schretlen D.J., Bonson K.R., Zhou Y., Nandi A., Brasic J.R., Kimes A.S., Maris M.A., Kumar A., Contoreggi C., Links J., Ernst M., Rousset O., Zukin S., Grace A.A., Lee J.S., Rohde C., Jasinski D.R., Gjedde A., London E.D. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 2006, 31:2716-2727.
50. Wu Y., Carson R.E. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow Metab. 2002, 22:1440-1452.
51. Xi Z.X., Gardner E.L. Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction. CNS Drug Rev. 2007, 13:240-259.
52. Xi Z.X., Li X., Li J., Peng X.Q., Song R., Gaal J., Gardner E.L. Blockade of dopamine D(3) receptors in the nucleus accumbens and central amygdala inhibits incubation of cocaine craving in rats. Addict. Biol. 2013, 18:665-677.